1. Home
  2. CNTN vs QUIK Comparison

CNTN vs QUIK Comparison

Compare CNTN & QUIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canton Strategic Holdings Inc. Common Stock

CNTN

Canton Strategic Holdings Inc. Common Stock

BUY

Current Price

$1.75

Market Cap

178.5M

Sector

Health Care

ML Signal

BUY

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

BUY

Current Price

$9.27

Market Cap

196.7M

Sector

Technology

ML Signal

BUY

Company Overview

Basic Information
Metric
CNTN
QUIK
Founded
2017
1988
Country
United States
United States
Employees
N/A
51
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
178.5M
196.7M
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
CNTN
QUIK
Price
$1.75
$9.27
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $23.00
AVG Volume (30 Days)
★ 729.5K
171.3K
Earning Date
11-11-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 88.10
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $20,112,000.00
Revenue This Year
N/A
$73.33
Revenue Next Year
N/A
$16.92
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.66
$5.28
52 Week High
$5.27
$24.33

Technical Indicators

Market Signals
Indicator
CNTN
QUIK
Relative Strength Index (RSI) 31.57 33.62
Support Level N/A $8.72
Resistance Level $3.80 $10.14
Average True Range (ATR) 0.13 0.45
MACD -0.07 -0.19
Stochastic Oscillator 3.49 16.31

Price Performance

Historical Comparison
CNTN
QUIK

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

Share on Social Networks: